Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Wael, Sumaya"'
Autor:
Wan Cheol Kim, MD, FRCPC, DRCPSC, Gregory Hirsch, MD, FRCSC, Catherine Kells, MD, FACC, FRCPC, FCCS, Ata-Ur-Rehman Quraishi, MBBS, FACC, FCPS, Helen Bishop, MD, FRCPC, Bakhtiar Kidwai, MBBS, MSc, MRCPI, Lawrence Title, MD, FRCPC, Hussein Beydoun, MBBS, FRCPC, FACC, Navjot Sandila, BSc, MPH, Wael Sumaya, MD, PhD, MRCP, Osama Elkhateeb, MD, FACC, FRCPC, DRCPSC
Publikováno v:
CJC Open, Vol 6, Iss 3, Pp 548-555 (2024)
Background: The study assessed the outcomes of patients undergoing percutaneous coronary intervention (PCI) to bypass grafts, focusing on all-cause mortality and target vessel failure (TVF) rates. Methods: A single-centre registry analysis included 3
Externí odkaz:
https://doaj.org/article/b401f53b7b4a4d5ba984052d3e86e466
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 19 (2022)
Externí odkaz:
https://doaj.org/article/9963c064eb214b8c8b33b82c7bb36cbc
Autor:
Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn, Robert F. Storey
Publikováno v:
Platelets, Vol 32, Iss 4, Pp 555-559 (2021)
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://doaj.org/article/3333115ba44f4ecd927f58c21aa5c9b6
Autor:
William A.E. Parker, Rachel C. Orme, Jessica Hanson, Hannah M. Stokes, Claire M. Bridge, Patricia A. Shaw, Wael Sumaya, Kirstie Thorneycroft, Giovanna Petrucci, Benedetta Porro, Heather M. Judge, Ramzi A. Ajjan, Bianca Rocca, Robert F. Storey
Publikováno v:
Platelets, Vol 30, Iss 2, Pp 148-157 (2019)
Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-anti
Externí odkaz:
https://doaj.org/article/b985dd267bf043f095a2e15eab57596f
Autor:
Lars Wallentin, Robert F. Storey, Anders Himmelmann, Katja Gabrysch, Ramzi A. Ajjan, Stefan James, Wael Sumaya, Agneta Siegbahn
Publikováno v:
Thrombosis and Haemostasis
Hypofibrinolysis is a key abnormality in diabetes but the role of impaired clot lysis in predicting vascular events and mortality in this population is yet to be determined. We aimed to investigate the relationship between fibrin clot properties and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1177e1f085880f63e0a1040d574c4ae0
https://doi.org/10.1055/s-0039-1701011
https://doi.org/10.1055/s-0039-1701011
Autor:
Rachel Orme, Zulfiquar Adam, William A E Parker, Wael Sumaya, Heather M Judge, Ian R Hall, Robert F. Storey, Kenneth P Morgan, Alexander M.K. Rothman, Julian Gunn, James D Richardson
Publikováno v:
Platelets
article-version (VoR) Version of Record
article-version (VoR) Version of Record
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9020dacd55ef2e25c26cf522a7f4bc2
Publikováno v:
JACC: Cardiovascular Interventions. 15:896-897
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72d389ce7bbe717fc78c178d495c9ed
https://doi.org/10.1016/j.jcin.2022.01.024
https://doi.org/10.1016/j.jcin.2022.01.024
Autor:
Daniel Duerschmied, C. Michael Gibson, Wael Sumaya, Samer Al Said, Samer Alabed, Hugo A. Katus, Klaus Kaier, Robert F. Storey, Dima Alsaid
Publikováno v:
Cochrane Database of Systematic Reviews.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f607f28889b2edbc5edc156b624cb3b
https://doi.org/10.1002/14651858.cd014678
https://doi.org/10.1002/14651858.cd014678
Autor:
Wael Sumaya, Robert F. Storey
Publikováno v:
Interventional Cardiology Clinics. 6:49-55
Platelet P2Y12 receptor inhibitors are crucial in the treatment of patients with acute coronary syndrome or undergoing percutaneous coronary intervention. Ticagrelor is a reversibly binding, potent oral P2Y12 inhibitor that also is a weak inhibitor o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::567d7b49472e5cd3b32ce49a55ebc219
https://doi.org/10.1016/j.iccl.2016.08.004
https://doi.org/10.1016/j.iccl.2016.08.004
Autor:
Wael Sumaya, Robert F. Storey
Publikováno v:
European Heart Journal. 39:209-211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ff3338a5d8e32cffb848beb3817dff
https://doi.org/10.1093/eurheartj/ehx660
https://doi.org/10.1093/eurheartj/ehx660